Compare A & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | HLN |
|---|---|---|
| Founded | 1999 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8B | 43.7B |
| IPO Year | 1999 | N/A |
| Metric | A | HLN |
|---|---|---|
| Price | $129.42 | $10.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 1 |
| Target Price | ★ $165.13 | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 7.9M |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | 0.77% | ★ 1.68% |
| EPS Growth | 3.16 | ★ 41.64 |
| EPS | ★ 4.57 | 0.23 |
| Revenue | $6,948,000,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $8.00 | $1.51 |
| Revenue Next Year | $6.25 | $4.67 |
| P/E Ratio | ★ $29.10 | $47.13 |
| Revenue Growth | ★ 6.73 | N/A |
| 52 Week Low | $96.43 | $8.71 |
| 52 Week High | $160.27 | $11.42 |
| Indicator | A | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 33.91 | 71.79 |
| Support Level | $131.56 | $10.28 |
| Resistance Level | $137.85 | $10.57 |
| Average True Range (ATR) | 3.69 | 0.16 |
| MACD | -0.73 | 0.05 |
| Stochastic Oscillator | 2.25 | 94.22 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.